Improving Patient Lives with Single Cell Precision
HiFiBiO Therapeutics, a clinical-stage global biotech, is pioneering a unique high-resolution translational platform (DIS®) to enhance the probability of success for immunotherapies
HiFiBiO Therapeutics, a clinical-stage global biotech, is pioneering a unique high-resolution translational platform (DIS®) to enhance the probability of success for immunotherapies
Our Science
We apply single cell science at every stage of drug development from target discovery to predictive biomarkers, enabling rapid advancement of new therapeutics into the clinic.
Read moreOur SOAR Values
We unite under a shared mission to SOAR to new heights in science and healthcare.
Read moreEntrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future CAMBRIDGE, Mass. – Apr 17, 2024 –– Ernst & Young LLP (EY US) today announced that Liang Schweizer, PhD, CEO, Chairperson, and Founder of HiFiBiO Therapeutics was named an Entrepreneur Of The Year® 2024 New England Award finalist. Now in its 38th year, … Continued
CAMBRIDGE, Mass. – Apr 16, 2024 – HiFiBiO Therapeutics, a clinical stage biotech company focusing on improving patient lives with single cell precision, today announced a new grant awarded by the Patient-Led Research Fund, a project of Patient-Led Research Collaborative and funded by Balvi. This grant is dedicated to a research initiative in collaboration with … Continued
CAMBRIDGE, MA – April 7, 2024 – HiFiBiO Therapeutics, a leading clinical stage global biotechnology company committed to advancing patient outcomes through single-cell precision, presented two posters at the AACR 2024 meeting held on April 5-10, 2024, in San Diego, CA. “One of the major challenges cancer immunotherapies face is the difficulties in selecting patients … Continued
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future CAMBRIDGE, Mass. – Apr 17, 2024 –– Ernst & Young LLP (EY US) today announced that Liang Schweizer, PhD, CEO, Chairperson, and Founder of HiFiBiO Therapeutics was named an Entrepreneur Of The Year® 2024 New England Award finalist. Now in its 38th year, … Continued
HiFiBiO Therapeutics single-cell focused platform identifies translationally relevant targets, enables rapid drug development, and matches treatments to patients for better clinical outcomes